You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MDS/MPN with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T)

Showing 1 - 25 of 9,748
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myelodysplastic/Myeloproliferative Tumor With Ring Sideroblasts and Thrombocytosis, Myelodysplastic/Myeloproliferative Tumor,

Recruiting
  • Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis
  • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 6, 2023

MDS Trial in Beijing (Roxadustat, Luspatercept)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Beijing, China
    Peking union medical college hospital
Aug 17, 2023

MDS/MPN Trial in Nanjing (Azacitidine (AZA) with Ruxolitinib)

Recruiting
  • MDS/MPN
  • Azacitidine (AZA) with Ruxolitinib
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital of Nanjing Medical University
Apr 17, 2023

Acute Myeloid Leukemia, Myeloproliferative Tumor, Myelodysplastic/Myeloproliferative Tumor Trial in Canada, United States

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Birmingham, Alabama
  • +9 more
Aug 30, 2021

MDS, Myeloproliferative Tumor, Anemia Trial in Tampa (Luspatercept)

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • Tampa, Florida
    Moffitt Cancer Center
Feb 16, 2023

MDS Trial in Beijing (Lenalidomide, Azacitidine)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Beijing, China
    Peking union medical college hospital
Aug 16, 2023

Clonal Cytopenia of Undetermined Significance, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Los Angeles

Not yet recruiting
  • Clonal Cytopenia of Undetermined Significance
  • +4 more
  • Biospecimen Collection
  • +6 more
  • Los Angeles, California
  • +1 more
Oct 4, 2023

Acute Myeloid Leukemia, MDS, Myelodysplastic/Myeloproliferative Tumor Trial in Worldwide (BGB-11417, Azacitidine, Posaconazole)

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Houston, Texas
  • +23 more
Aug 18, 2022

Myelofibrosis, Polycythemia Vera Trial in United States (TGR-1202, ruxolitinib)

Active, not recruiting
  • Myelofibrosis
  • Polycythemia Vera
  • Phoenix, Arizona
  • +4 more
Jun 20, 2022

MDS, Anemia Trial in Germany (Luspatercept Injection)

Recruiting
  • Myelodysplastic Syndromes
  • Anemia
  • Luspatercept Injection
  • Berlin, Germany
  • +18 more
Jan 25, 2023

Myeloproliferative Tumor, Polycythemia Vera, Essential Thrombocythemia Trial in Hong Kong

Recruiting
  • Myeloproliferative Neoplasm
  • +7 more
    • Hong Kong, Hong Kong
      Department of Medicine, Queen Mary Hospital
    May 21, 2023

    Biospecimen Acquisition for Myelodysplastic Syndromes

    Recruiting
    • Myelodysplastic Syndromes
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Aug 20, 2022

      The National Myelodysplastic Syndromes (MDS) Study

      Recruiting
      • Myelodysplastic Syndromes (MDS)
      • Therapeutic
      • Anaheim, California
      • +280 more
      Apr 8, 2022

      MDS Trial in Germany (Luspatercept)

      Recruiting
      • Myelodysplastic Syndromes
      • Hamburg, Germany
      • +4 more
      Dec 20, 2021

      Action of Interferon in Treatment of Myeloproliferative

      Recruiting
      • Myeloproliferative Neoplasm
        • Villejuif, Ile De France, France
          Inserm U1287
        Apr 28, 2023

        MDS, MDS Trial in France (Luspatercept Injection [Reblozyl], Eprex)

        Recruiting
        • MDS
        • Myelodysplastic Syndromes
        • Luspatercept Injection [Reblozyl]
        • Eprex
        • Amiens, France
        • +30 more
        May 19, 2022

        Iron Deficiency Anemia Trial in Australia, Israel, Romania (KER-047)

        Recruiting
        • Iron Deficiency Anemia
        • Adelaide, South Australia, Australia
        • +8 more
        Jun 23, 2023

        MDS, Ferroptosis Trial in Pessac (Biological sampling)

        Not yet recruiting
        • Myelodysplastic Syndromes
        • Ferroptosis
        • Biological sampling
        • Pessac, France
        • +2 more
        Jun 19, 2023

        Primary Myelofibrosis, Polycythemia Vera, Essential Thrombocythemia Trial in Toronto (Observational)

        Recruiting
        • Primary Myelofibrosis
        • +9 more
        • Observational
        • Toronto, Ontario, Canada
          Princess Margaret Cancer Centre
        Apr 11, 2022

        Myelodysplastic/Myeloproliferative Tumors, Adult Trial in Suzhou (venetoclax combined with azacitidine)

        Enrolling by invitation
        • Myelodysplastic/Myeloproliferative Neoplasms
        • Adult
        • venetoclax combined with azacitidine
        • Suzhou, Jiangsu, China
          The First Affiliated Hospital of Soochow University, Jiangsu Ins
        Mar 7, 2022

        Myelodysplastic/Myeloproliferative Tumor, Steroid Refractory GVHD, Allogeneic Hematopoietic Cell Transplant Trial in Toronto

        Completed
        • Myelodysplastic/Myeloproliferative Neoplasm
        • +2 more
        • Decidual stromal cells (DSC)
        • Toronto, Ontario, Canada
          Princess Margaret Cancer Centre
        Jan 8, 2023

        Acute Myeloid Leukemia, Leukemia, Leukemia, Myeloid Trial in Boston (Cytokine Induced Memory-like Natural Killer Cells,

        Not yet recruiting
        • Acute Myeloid Leukemia
        • +5 more
        • Cytokine Induced Memory-like Natural Killer Cells
        • Interleukin-2
        • Boston, Massachusetts
        • +1 more
        Nov 14, 2023

        Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission, Adult

        Terminated
        • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
        • +9 more
        • Allogeneic Bone Marrow Transplantation
        • +7 more
        • Seattle, Washington
          Fred Hutch/University of Washington Cancer Consortium
        Oct 4, 2021

        Philadelphia Negative Myeloproliferative Tumors Trial

        Not yet recruiting
        • Philadelphia Negative Myeloproliferative Neoplasms
          • (no location specified)
          Jun 5, 2022

          MDS/MPN Trial in Nashville (ASTX727, Itacitinib)

          Recruiting
          • MDS/MPN
          • Nashville, Tennessee
            Vanderbilt-Ingram Cancer Center
          Jun 20, 2022